Dukaamaysiga & Barashada
2023-dhs-website-summary-v.1.pdf
Natiijooyinka Raadinta
Soo bandhiga 1511 - 1520 ee natiijooyinka 5432
Bixiye
QP73-23 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective October 1, 2023
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 13, 2023
Bixiye
QP74-23 Commercial Pharmacy Benefit Exclusion for Abilify Asimtufii®, Adstiladrin®, Brixadi™, Glydo®, lidocaine 2%, Roctavian™, and Uzedy™
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 13, 2023
Bixiye
QP75-23 MHCP Pharmacy Benefit Exclusion for Adstiladrin®, Brixadi™, and Roctavian™
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 13, 2023
Bixiye
QP76-23 Commercial Pharmacy Benefit Exclusion for Sublocade®
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 13, 2023
Bixiye
P59-23 Services Removed from the Commercial Prior Authorization List
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2023
Bixiye
P60-23 Home Health Agencies are Required to Provide Minnesota Home Care Bill of Rights for Clients
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2023
Bixiye
P61-23 Inpatient Hospital Admission Prior Authorization Removed for Medicare Advantage; Pre-Admission Notification Required
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2023
Bixiye
P62-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Medical Oncology Drug Prior Authorization Updates
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2023
Bixiye
P63-23 New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective November 6, 2023
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2023